ENZO在鑒定、合成、商業(yè)化生產(chǎn)生物活性化合物方面具有豐富的經(jīng)驗，其提供的Screen-Well?化合物庫系列產(chǎn)品，可為化合物篩選提供簡單、快捷的分析手段。化合物庫中包含多類抑制劑、激活劑、誘導(dǎo)劑等3000多種小分子，產(chǎn)品說明書中提供完整的化合物活性描述、物理性質(zhì)、結(jié)構(gòu)組成等信息。
?產(chǎn)品名稱 | ?產(chǎn)品編號 |
?Screen-Well???Histaminergic?ligand?library?(100?ul/well) | ?BML-2816-0100 |
?Screen-Well???Adrenergic?ligand?library?(100?ul/well) | ?BML-2811-0100 |
?Screen-Well???Metabotropic?glutamatergic?ligand?library?(100?ul/well) | ?BML-2818-0100 |
?Screen-Well???Dopaminergic?ligand?library?(100?ul/well) | ?BML-2812-0100 |
?Screen-Well???Phosphatase?inhibitor?library?(100?ul/well) | ?BML-2834-0100 |
?Screen-Well???REDOX?library?100?ul/well | ?BML-2835-0100 |
?Screen-Well???Fatty?Acid?library?(100?ul/well) | ?BML-2803-0100 |
?Screen-Well???Wnt?Pathway?library?100?ul/well | ?BML-2838-0100 |
?Screen-Well???Purinergic?ligand?library?(100?ul/well) | ?BML-2820-0100 |
?Screen-Well???Fatty?acid?library?(500?ul/well) | ?BML-2803-0500 |
?Screen-Well???Nuclear?Receptor?ligand?library?(100?ul/well) | ?BML-2802-0100 |
?Screen-Well???Hematopoietic?library?(100ul?per?well) | ?BML-2852-0100 |
?Screen-Well???Autophagy?library | ?BML-2837-0500 |
?Screen-Well???Cardiotoxicity?library??(100ul?per?well) | ?BML-2850-0100 |
?Screen-Well???Endocannabinoid?library?(500?ul/well) | ?BML-2801-0500 |
?Screen-Well???Orphan?ligand?library?(500?ul/well) | ?BML-2825-0500 |
?Screen-Well???Epigenetics?library?(500?ul/well) | ?BML-2836-0500 |
?Screen-Well???Cholinergic?ligand?library?(100?ul/well) | ?BML-2815-0100 |
?Screen-Well???Epigenetics?library?(100?ul/well) | ?BML-2836-0100 |
?Screen-Well???Autophagy?library | ?BML-2837-0100 |
?Screen-Well???Kinase?inhibitor?library?(100?ul/well) | ?BML-2832-0100 |
?Screen-Well???Heptatoxicity?library?(100ul?per?well) | ?BML-2851-0100 |
?Screen-Well???Kinase?inhibitor?library?(500?ul/well) | ?BML-2832-0500 |
?Screen-Well???Ion?Channel?ligand?library?(500?ul/well) | ?BML-2805-0500 |
?Screen-Well???Hematopoietic?library??(500ul?per?well) | ?BML-2852-0500 |
?Screen-Well???Phosphatase?inhibitor?library?(500?ul/well) | ?BML-2834-0500 |
?Screen-Well???Cardiotoxicity?library?(500ul?per?well) | ?BML-2850-0500 |
?Screen-Well???Neurotransmitter?library?(10?plate?set)?(100ul/well) | ?BML-2810-0100 |
?Screen-Well???Wnt?Pathway?library?500?ul/well | ?BML-2838-0500 |
?Screen-Well???Bioactive?Lipid?library?(500?ul/well) | ?BML-2800-0500 |
?Screen-Well???Nuclear?Receptor?ligand?library?(500?ul/well) | ?BML-2802-0500 |
?Screen-Well???FDA?approved?Drug?library?V2 | ?BML-2843-0100 |
?Screen-Well???Endocannabinoid?library?(100?ul/well) | ?BML-2801-0100 |
?Screen-Well???REDOX?library?(500?ul/well) | ?BML-2835-0500 |
?Screen-Well???ICCB?known?bioactives?library?(100?ul/well) | ?BML-2840-0100 |
?Screen-Well???Protease?inhibitor?library?(100?ul/well) | ?BML-2833-0100 |
?Screen-Well???Protease?inhibitor?library?(500?ul/well) | ?BML-2833-0500 |
?Screen-Well???Natural?Product?library?(100?ul/well) | ?BML-2865-0100 |
?Screen-Well???Natural?Product?library?500?ul/well | ?BML-2865-0500 |
?Screen-Well???Ion?Channel?ligand?library?(100?ul?per?well) | ?BML-2805-0100 |
?Screen-Well???Bioactive?Lipid?library?(100?ul/well) | ?BML-2800-0100 |
?Screen-Well???Serotonergic?ligand?library?(100?ul/well) | ?BML-2813-0100 |
?Screen-Well???Neurotransmitter?library?(10?plate?set)?(500?ul/well) | ?BML-2810-0500 |
?Screen-Well???Heptatoxicity?library??(500ul?per?well) | ?BML-2851-0500 |
?Screen-Well???GABAergic?ligand?library?(100?ul/well) | ?BML-2819-0100 |
?Screen-Well???Ionotropic?glutamatergic?ligand?library?(100?ul/well) | ?BML-2817-0100 |
?Screen-Well???Nephrotoxicity?Library?(100ul/well) | ?ENZ-LIB100-0100 |
?Screen-Well???Serotonergic?ligand?library?(500?ul/well) | ?BML-2813-0500 |
?Screen-Well???Opioid?ligand?library?(500?ul/well) | ?BML-2814-0500 |
?Screen-Well???Purinergic?ligand?library?(500?ul/well) | ?BML-2820-0500 |
?Screen-Well???Dopaminergic?ligand?library?(500?ul/well) | ?BML-2812-0500 |
?Screen-Well???Cholinergic?ligand?library?(500?ul/well) | ?BML-2815-0500 |
?Screen-Well???Metabotropic?Glutamatergic?ligand?library?(500?ul/well) | ?BML-2818-0500 |
?Screen-Well???Adrenergic?ligand?library?(500?ul/well) | ?BML-2811-0500 |
?Screen-Well???GABAergic?ligand?library?(500?ul/well) | ?BML-2819-0500 |
?Screen-Well???Ionotropic?Glutamatergic?ligand?library?(500?ul/well) | ?BML-2817-0500 |
?Screen-Well???Opioid?ligand?library?(100?ul/well) | ?BML-2814-0100 |
?Screen-Well???Histaminergic?ligand?library?(500?ul/well) | ?BML-2816-0500 |
?Screen-Well???Myotoxicity?library | ?ENZ-LIB101-0100? |
文獻引用
-----------------------------------------------------------------------------------------------------------------------------
1.?Identification?of?trichlormethiazide?as?a?Mdr1a/b?gene?expression?enhancer?via?a?dual?secretion-based?promoter?assay:?S.?Schulze,?et?al.;?
?? ?Pharma.?Res.?Per.?3,?e00109?(2015),?Application(s):?Cell?Culture,?Full?Text
2.?3D?high-content?screening?for?the?identification?of?compounds?that?target?cells?in?dormant?tumor?spheroid?regions:?C.?Wenzel,?et?al.;?Exp.?
??? Cell?Res.?15,?323?(2014),?Abstract;
3.?A?yeast-based?assay?identifies?drugs?that?interfere?with?Epstein-Barr?virus?immune?evasion:?C.?Voisset,?et?al.;?Dis.?Model?Mech.7,?435?(2014),?
????Abstract;?Full?Text
4.?Antifungal?Application?of?Nonantifungal?Drugs:?M.?Stylianou,?et?al.;?Antimicrob.?Agents?Chemother.?58,?1055?(2014),Application(s):?In?vitro?
??? susceptibility?testing?of?C.?albicans?strain?SC5314,?Abstract;?Full?Text
5.?Fluoxetine?prevents?dystrophic?changes?in?a?zebrafish?model?of?Duchenne?muscular?dystrophy?:?T.A.?Waugh,?et?al.;?Hum.?Mol.?Genet.?23,?4651?(2014),?
????Application(s):?Drug?screening?in?zebrafish?model?of?Duchenne?muscular?dystrophy,?Abstract;
6.?Host-Directed?Antimicrobial?Drugs?with?Broad-Spectrum?Efficacy?against?Intracellular?Bacterial?Pathogens:?D.M.?Czyz,?et?al.?;?mBio?5,?e01534?(2014),?
????Application(s):?Screening?of?FDA-approved?drugs?for?compounds?that?block?the?intracellular?growth?ofC.?burnetii?in?THP-1?cells,?Abstract;?Full?Text
7.?Fluorescent?dye?cocktail?for?multiplex?drug-site?mapping?on?human?serum?albumin:?J.C.?Er,?et?al.;?ACS?Comb.?Sci.?15,?452?(2013),?Abstract;
8.?Miniature?short?hairpin?RNA?screens?to?characterize?antiproliferative?drugs:?S.?Kittanakom,?et?al.;?G3?(Bethesda)?3,?1375?(2013),Application(s):
????Screening?of?A549?cells,?Abstract;?Full?Text
9.?Systematic?evaluation?of?640?FDA?drugs?for?their?effect?on?CD4?Foxp3??regulatory?T?cells?using?a?novel?cell-based?high?throughput?screening?assay:?
??? R.?Mao,?et?al.;?Biochem.?Pharmacol.?85,?1513?(2013),?Abstract;
10.?The?toll-like?receptor?agonist?imiquimod?is?active?against?prions:?N.?Oumata,?et?al.;?PLoS?One?8,?e72112?(2013),?Abstract;?Full?Text
11.?Identification?of?Modulators?of?Hair?Cell?Regeneration?in?the?Zebrafish?Lateral?Line:?P.?Namdara,et?al.?;?J.?Neurosci.?32,?3516?(2012),?Application?(s):?
????? Chemical?screen?for?modulators?of?hair?cell?regeneration?using?zebrafish?lateral?line?neuromasts?as?a?platform,?Abstract;?Full?Text
12.?Systematic?identification?of?synergistic?drug?pairs?targeting?HIV:?X.?Tan,?et?al.;?Nat.?Biotechnol.?30,?1125?(2012),?Abstract;